As a pioneer in stem cell research and treatment in Malaysia, Cytopeutics Sdn. Bhd. has worked extensively with Syngene on multiple preclinical projects such as safety (toxicity and tumorigenicity) and proof-of-concept studies for our new investigational product. We were consistently impressed with how efficiently the studies were initiated and progressed, within the stipulated timeline, despite the incredibly tight schedule and budget. We are extremely pleased with Syngene's outstanding quality of work, excellent professionalism, and the high level of dedication of each team member to our studies. With Syngene's help, we could complete our preclinical studies in time to support our clinical trials and product registration requirements. We look forward to working together again.

"We were extremely impressed by Syngene's toxicology expertise, turnaround time, and responsiveness, as well as the quality of their reports. They delivered well ahead of our planned submission timeline, which significantly supported our regulatory progression. The seamless coordination between their scientific and project management teams ensured timely updates and smooth execution throughout the program. The quality across their services-including genotoxicity, analytical support, bioanalysis, in vivo toxicology, and SEND datasets-exceeded expectations. Whenever we needed modifications or had specific requirements, Syngene addressed them professionally and with exceptional flexibility."

"Syngene's team demonstrated outstanding professionalism and deep technical expertise. Their scientists managed the studies-including rodent and miniature pig models-efficiently and with great attention to detail. The timelines provided by Syngene were among the best we've experienced in the industry, helping us secure timely FDA approval for our product."

"We engaged Syngene's Safety Assessment team for multiple IND-enabling programs aimed at EMA/MHRA submissions. We have been partnering with Syngene for several years now. Their timelines, study quality, and scientific expertise-especially in nonclinical toxicology-have consistently exceeded expectations. Whether it is an early exploratory MTD study or a full IND package, Syngene ensures studies are designed and executed to our specifications while maintaining the highest quality standards."

"The communication and professionalism of the Syngene toxicology team were outstanding. The study ran smoothly, and the final report was exceptionally well written. The Study Director managed the program efficiently and kept us informed at every stage of progress and results."

"We have been collaborating with Syngene's Safety Assessment team for close to a decade for both regulatory and mechanistic safety studies across our agrochemical portfolio. Syngene's scientific capabilities, responsiveness, and turnaround times are consistently excellent. They proactively adopt new methods and approaches to meet project needs. Feedback from internal reviewers and regulatory authorities has repeatedly validated the high quality of Syngene's work"